Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024
... Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2024
... G-Protein Coupled Receptor (GPCR) Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, ... Read More
-
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024
... Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024
... Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024
... Leukemia-Lymphoma market. A detailed picture of the Adult T-Cell Leukemia-Lymphoma pipeline landscape is provided, which includes the disease overview and Adult T-Cell Leukemia-Lymphoma treatment guidelines. The assessment part of the report embraces in-depth Adult T-Cell ... Read More
-
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024
... development scenario and growth prospects across the Advanced Breast Cancer in Premenopausal Women market. A detailed picture of the Advanced Breast Cancer in Premenopausal Women pipeline landscape is provided, which includes the disease overview and ... Read More
-
Advanced Heart Failure - Pipeline Insight, 2024
... Failure market. A detailed picture of the Advanced Heart Failure pipeline landscape is provided, which includes the disease overview and Advanced Heart Failure treatment guidelines. The assessment part of the report embraces in-depth Advanced Heart ... Read More
-
Advanced Pancreatic Cancer - Pipeline Insight, 2024
... Cancer market. A detailed picture of the Advanced Pancreatic Cancer pipeline landscape is provided, which includes the disease overview and Advanced Pancreatic Cancer treatment guidelines. The assessment part of the report embraces in-depth Advanced Pancreatic ... Read More
-
Age-related Macular Degeneration (AMD) - Pipeline Insight, 2024
... the Age-related Macular Degeneration (AMD) market. A detailed picture of the Age-related Macular Degeneration (AMD) pipeline landscape is provided, which includes the disease overview and Age-related Macular Degeneration (AMD) treatment guidelines. The assessment part of ... Read More
-
Alcohol Addiction - Pipeline Insight, 2024
... picture of the Alcohol Addiction pipeline landscape is provided, which includes the disease overview and Alcohol Addiction treatment guidelines. The assessment part of the report embraces in-depth Alcohol Addiction commercial assessment and clinical assessment of ... Read More
-
Alcoholic steatohepatitis - Pipeline Insight, 2024
... picture of the Alcoholic steatohepatitis pipeline landscape is provided, which includes the disease overview and Alcoholic steatohepatitis treatment guidelines. The assessment part of the report embraces in-depth Alcoholic steatohepatitis commercial assessment and clinical assessment of ... Read More
-
Allogenic Cell Therapies - Pipeline Insight, 2024
... Therapies market. A detailed picture of the Allogenic Cell Therapies pipeline landscape is provided, which includes the disease overview and Allogenic Cell Therapies treatment guidelines. The assessment part of the report embraces in-depth Allogenic Cell ... Read More
-
Klebsiella Pneumoniae Infections - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Glabellar Lines - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
TYK2 kinase inhibitors - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). Analysts at DelveInsight project that approximately 54% of the Total Diagnosed Prevalent Cases of Molybdenum Cofactor Deficiency Type ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
... years, immunotherapy has undergone a new phase of development which is linked to the development of CAR-T cell therapy. It is anticipated that CAR-T cells will bring out the next big leap forward in leukemia ... Read More
-
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2034
... the 7MM is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that among the total diagnosed prevalent cases of myasthenia gravis in 7MM approximately 45% of cases were from the ... Read More
-
Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
... growing adult population, which is more prone to idiopathic pulmonary arterial hypertension, is adding to the increased cases of pulmonary arterial hypertension. The pulmonary arterial hypertension market is projected to witness consistent growth throughout the ... Read More
-
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2024
... 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor development. The report ... Read More
-
Chemotherapy Induced Neutropenia - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) - Pipeline Insight, 2024
... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More
-
Chemotherapy Induced Febrile Neutropenia - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Cholestatic Pruritus- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Cholestatic ... Read More
Research Assistance
